Forward Pharma A/S (FWP) |
| 1.95 0 (0%) 12-27 16:00 |
| Open: | 1.94 |
| High: | 2.06 |
| Low: | 1.94 |
| Volume: | 43,354 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 6.2797 |
| 52w Low: | 1.43 |
Forward Pharma A/S currently conducts no significant business activities. In its prior operations, the company functioned as a biopharmaceutical firm. It dedicated its efforts to advancing FP187, its exclusive formulation of dimethyl fumarate, designed to address inflammatory and neurological disorders. Forward Pharma A/S was founded in 2005 and maintains its corporate headquarters in Copenhagen, Denmark.
Financials
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Company news
Fri, 05 Jan 2018
- SEC.gov
Sun, 02 Aug 2026
Sun, 02 Aug 2026
Sun, 02 Aug 2026
Sun, 02 Aug 2026
Sun, 02 Aug 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
